Growing Through Challenges? – Cyclo Therapeutics Inc (CYTH)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Cyclo Therapeutics Inc (NASDAQ:CYTH). The institutional investor has increased its shareholding in the Healthcare company by 9.68% to 0.28 million shares with purchase of 24888.0 shares. This fresh investment now brings its stake to 1.24% valued currently at $0.45 million. In addition, Geode […]
